Y Intercept (Hong Kong) LTD Acadia Pharmaceuticals Inc Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 32,905 shares of ACAD stock, worth $563,004. This represents 0.04% of its overall portfolio holdings.
Number of Shares
32,905
Previous 50,544
34.9%
Holding current value
$563,004
Previous $777,000
22.39%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding ACAD
# of Institutions
315Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$734 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$239 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$206 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$149 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.77B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...